Pharmafile.com’s weekly COVID-19 news round-up
May 27, 2020Research and Development COVID-19, coronavirus, coronavirus round up
COVID-19 vaccines and treatments continue to dominate the news, as AstraZeneca is attempting to deliver one billion doses of coronavirus …
NICE reverses previous stance to recommend Roche’s Tecentriq in extensive-stage small-cell lung cancer
May 27, 2020Research and Development, Sales and Marketing NICE, Roche, lung cancer, tecentriq
NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new …
Remdesivir available to select COVID-19 patients through the NHS
May 27, 2020Research and Development coronavirus, covid19
Gilead Sciences Ebola drug remdesivir will be available for selected patients who are suffering from coronavirus through the NHS. The …
Living with multiple ‘invisible’ conditions
May 26, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease
Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …
Scientists working on UK COVID-19 vaccine say there is now only a 50% chance of success due to falling cases
May 26, 2020Manufacturing and Production COVID-19, coronavirus
Researchers working on a COVID-19 vaccine are facing a race against time due to falling rates of the virus threatening …
Hot and humid weather can slow COVID-19 transmission, new study finds
May 26, 2020Manufacturing and Production COVID-19, coronavirus
A new study from the Massachusetts Institute of Technology, Harvard, Virginia Tech and the University of Connecticut has shown that …
FDA approves Takeda’s first-line treatment option for non-small cell lung cancer
May 26, 2020Manufacturing and Production FDA, Takeda, approval
The FDA has approved Takeda’s Alunbrig (brigatinib) for adult patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer …
Cleaning staff excluded from GSK’s £1.5k COVID-19 employee bonus
May 26, 2020Manufacturing and Production COVID-19, GSK, coronavirus, pharma
UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …
WHO stops hydroxychloroquine trial due to safety concerns
May 26, 2020Manufacturing and Production COVID, COVID-19, coronavirus
The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, …
Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines
May 21, 2020Research and Development COVID-19, vaccine coronavirus
“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …
UK begins hydroxychloroquine trial
May 21, 2020Business Services COVID-19, coronavirus, hydroxychloroquine
A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK. The first participants will be enrolled …
Two billion people are at high risk of contracting COVID-19 due to poor sanitation
May 21, 2020Business Services COVID-19, coronavirus, sanitation
About a quarter of the world’s population are at higher risk of catching the COVID-19 coronavirus due to a lack …
Researchers plan to use machine learning methods to estimate the seasonal cycle of COVID-19 in the US
May 21, 2020Business Services COVID-19, coronavirus
Scientists at the Lawrence Berkeley National Laboratory are launching a project to apply machine learning methods to map the severity, …
AstraZeneca targets one billion COVID-19 vaccines by September
May 21, 2020Business Services COVID-19, Vaccine, coronavirus, coronavirus vaccine
AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration …
Pharmafile.com’s weekly COVID-19 news round-up
May 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus
Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …
MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic
May 20, 2020Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory
A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …
New research outlines guidelines for the ethical use of AI in healthcare
May 20, 2020Research and Development AI, coronavirus
A new study published in The Lancet has called on the global health community to establish guidelines to develop and …
Nanotechnology could be used to assess mortality risk in COVID-19 patients
May 20, 2020Research and Development COVID-19, coronavirus, nanotechnology
Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …
Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS
May 20, 2020Research and Development COVID-19, Diabetics, coronavirus, diabetes
People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …
Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope
May 19, 2020Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma
Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
